Display options
Cite
Bińkowska M, Jakiel G, Paszkowski T, et al. Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg. Prz Menopauzalny. 2021;20(3):113-115doi: 10.5114/pm.2021.109887.
Bińkowska, M., Jakiel, G., Paszkowski, T., Skrzypulec-Plinta, V., & Zgliczyński, W. (2021). Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg. Przeglad menopauzalny = Menopause review, 20(3), 113-115. https://doi.org/10.5114/pm.2021.109887
Bińkowska, Małgorzata, et al. "Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg." Przeglad menopauzalny = Menopause review vol. 20,3 (2021): 113-115. doi: https://doi.org/10.5114/pm.2021.109887
Bińkowska M, Jakiel G, Paszkowski T, Skrzypulec-Plinta V, Zgliczyński W. Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg. Prz Menopauzalny. 2021 Sep;20(3):113-115. doi: 10.5114/pm.2021.109887. Epub 2021 Oct 11. PMID: 34703410; PMCID: PMC8525257.
Copy Download .nbib Format: NLM
Share it on

Prz Menopauzalny. 2021 Sep;20(3):113-115. doi: 10.5114/pm.2021.109887. Epub 2021 Oct 11.

Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg.

Przeglad menopauzalny = Menopause review

Małgorzata Bińkowska, Grzegorz Jakiel, Tomasz Paszkowski, Violetta Skrzypulec-Plinta, Wojciech Zgliczyński

Affiliations

  1. I Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education in Warsaw, Poland.
  2. III Chair and Department of Gynecology, Medical University of Lublin, Poland.
  3. Chair of Women's Health, Medical University of Silesia in Katowice, Poland.
  4. Department of Endocrinology, Centre of Postgraduate Medical Education in Warsaw, Poland.

PMID: 34703410 PMCID: PMC8525257 DOI: 10.5114/pm.2021.109887

Abstract

At a meeting held on 20 May 2021, reviewed the available literature on the use of the medicinal product Bijuva® for the relief of menopausal symptoms.

Copyright © 2021 Termedia.

Conflict of interest statement

The authors report no conflicts of interest.

References

  1. Climacteric. 2016 Apr;19(2):109-50 - PubMed
  2. Endocr Pract. 2017 Jul;23(7):869-880 - PubMed
  3. Menopause. 2019 Jul;26(7):720-727 - PubMed
  4. Post Reprod Health. 2020 Dec;26(4):181-209 - PubMed
  5. Prz Menopauzalny. 2019 Apr;18(1):1-8 - PubMed
  6. Menopause. 2020 Sep 14;28(1):32-39 - PubMed
  7. Menopause. 2020 Nov;27(11):1236-1241 - PubMed
  8. JAMA. 1995 Jan 18;273(3):199-208 - PubMed
  9. PLoS One. 2013 Nov 01;8(11):e78016 - PubMed
  10. Post Reprod Health. 2014 May 22;20(2):69-72 - PubMed
  11. Menopause. 2019 May;26(5):506-512 - PubMed
  12. Menopause. 2017 Jul;24(7):728-753 - PubMed
  13. Menopause. 2019 Jan 9;26(6):637-642 - PubMed
  14. Menopause. 2020 Dec;27(12):1382-1387 - PubMed
  15. Menopause. 2020 Apr;27(4):410-417 - PubMed
  16. Drugs Context. 2020 Dec 02;9: - PubMed
  17. Menopause. 2015 Dec;22(12):1308-16 - PubMed
  18. Best Pract Res Clin Obstet Gynaecol. 2020 Nov;69:13-29 - PubMed
  19. JAMA. 2003 Jun 25;289(24):3243-53 - PubMed
  20. J Menopausal Med. 2020 Aug;26(2):69-98 - PubMed
  21. Menopause. 2018 Dec 21;26(6):622-628 - PubMed
  22. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):340-5 - PubMed
  23. Menopause. 2020 Dec;27(12):1388-1395 - PubMed
  24. Expert Rev Clin Pharmacol. 2019 Aug;12(8):729-739 - PubMed
  25. Obstet Gynecol. 2018 Jul;132(1):161-170 - PubMed

Publication Types